<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01093703</url>
  </required_header>
  <id_info>
    <org_study_id>08-005049</org_study_id>
    <nct_id>NCT01093703</nct_id>
  </id_info>
  <brief_title>Chronotherapy Versus Conventional BP Control to Correct Abnormal Circadian BP Pattern in Kidney Transplant Recipients</brief_title>
  <official_title>Randomized Trial to Explore the Effect of Chronotherapy Versus Conventional BP Control to Correct Abnormal Circadian BP Pattern and Improve Allograft Function in Kidney Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify and manage factors related to blood pressure control
      that impact organ function and survival in kidney transplant recipients. Loss of the
      circadian (relating to a 24-hour rhythm) blood pressure pattern is common in kidney
      transplant recipients and is associated with poor allograft kidney function. It is still
      unclear if restoring the normal day-night blood pressure (BP) pattern will translate into
      better allograft outcome. Although studies in patients with and without chronic kidney
      disease indicate that restoration of the normal nocturnal (night) dipping in BP is possible
      by changing the timing of the BP medications to cover the overnight period (chronotherapy),
      this has not been tested in kidney transplant patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The challenge in kidney transplantation is to identify and manage factors that impact
      allograft function and survival. Loss of the circadian blood pressure pattern is common in
      kidney transplant recipients and is associated with poor allograft kidney function.
      Nevertheless, it is unclear if restoring the normal day-night BP pattern will translate into
      better allograft outcome. Although studies in patients with and without chronic kidney
      disease indicate that restoration of the normal nocturnal dipping in BP is possible by
      changing the timing of the BP medications to cover the overnight period (chronotherapy), this
      has not been tested in kidney transplant patients. This exploratory study is driven by the
      hypothesis that chronotherapy will restore the normal circadian BP pattern and will translate
      into better allograft function and into lower LVM 1-year from transplantation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent drop in mean SBP at night-time compared to mean SBP in day-time</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Glomerular filtration rate</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Awake mean SBP</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of abnormal circadian BP pattern in recipients on steroid free and CIN free IS</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in LVM</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary microalbumin excretion</measure>
    <time_frame>4 months &amp; 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long term renal function</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular events (stroke, heart failure, myocardial infarction)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">99</enrollment>
  <condition>Blood Pressure Control</condition>
  <condition>Kidney Transplant Recipient</condition>
  <arm_group>
    <arm_group_label>Conventional Therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In the conventional therapy group, no medication changes other than the ones needed to achieve target awake average SBP will be undertaken. Time at which patients are taking their BP medications will be recorded.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intensive Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the intensive therapy group, BP medications will be adjusted to both control awake average systolic BP to target and to cover the overnight period in an attempt to control nocturnal hypertension.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medication Adjustment</intervention_name>
    <description>Awake SBP≤135/85mmHg and patient is on once daily medications: Switch BP medications to pm period.
Awake SBP SBP≤135/85mmHg and patient is on bid medications (e.g. metoprolol bid): Increase pm dose of the medication. If medication is already is at maximal dose or there is contraindication for increasing the dose (e.g. bradycardia), add another BP medicine in the evening time.
Awake SBP≤135/85mmHg and patient is not on anti-hypertensive medications: Add BP medication at the pm period.
Awake SBP&gt;135/85mmHg: increase dose of antihypertensive medications or add more medications. All medications to be given in the evening time.</description>
    <arm_group_label>Intensive Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recipient of a kidney transplant.

          -  Age≥18 years.

          -  Stable allograft function.

          -  Ability to give informed consent.

        Exclusion Criteria:

          -  Multiorgan transplant recipients.

          -  Kidney transplant recipients with poor allograft function.

          -  Documented history of obstructive sleep apnea.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mayoclinic.org/</url>
  </link>
  <reference>
    <citation>Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA. 2000 Feb 2;283(5):633-8.</citation>
    <PMID>10665703</PMID>
  </reference>
  <reference>
    <citation>Kasiske BL, Anjum S, Shah R, Skogen J, Kandaswamy C, Danielson B, O'Shaughnessy EA, Dahl DC, Silkensen JR, Sahadevan M, Snyder JJ. Hypertension after kidney transplantation. Am J Kidney Dis. 2004 Jun;43(6):1071-81.</citation>
    <PMID>15168388</PMID>
  </reference>
  <reference>
    <citation>Opelz G, Döhler B; Collaborative Transplant Study. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005 Nov;5(11):2725-31.</citation>
    <PMID>16212633</PMID>
  </reference>
  <reference>
    <citation>Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E; Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003 Jun 12;348(24):2407-15.</citation>
    <PMID>12802026</PMID>
  </reference>
  <reference>
    <citation>Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens. 1992 Aug;10(8):875-8.</citation>
    <PMID>1325522</PMID>
  </reference>
  <reference>
    <citation>Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994 Dec;24(6):793-801. Erratum in: Hypertension 1995 Mar;25(3):462.</citation>
    <PMID>7995639</PMID>
  </reference>
  <reference>
    <citation>Haydar AA, Covic A, Jayawardene S, Agharazii M, Smith E, Gordon I, O'Sullivan H, Goldsmith DJ. Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients. Transplantation. 2004 Mar 27;77(6):849-53.</citation>
    <PMID>15077025</PMID>
  </reference>
  <reference>
    <citation>Agarwal R, Andersen MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006 Apr;69(7):1175-80.</citation>
    <PMID>16467785</PMID>
  </reference>
  <reference>
    <citation>Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002 Sep 12;347(11):797-805.</citation>
    <PMID>12226150</PMID>
  </reference>
  <reference>
    <citation>Davidson MB, Hix JK, Vidt DG, Brotman DJ. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med. 2006 Apr 24;166(8):846-52. Erratum in: Arch Intern Med. 2006 Aug 14-28;166(15):1619.</citation>
    <PMID>16636209</PMID>
  </reference>
  <reference>
    <citation>Kapa S, Sert Kuniyoshi FH, Somers VK. Sleep apnea and hypertension: interactions and implications for management. Hypertension. 2008 Mar;51(3):605-8. doi: 10.1161/HYPERTENSIONAHA.106.076190. Epub 2008 Jan 28. Review.</citation>
    <PMID>18227409</PMID>
  </reference>
  <reference>
    <citation>Pennestri MH, Montplaisir J, Colombo R, Lavigne G, Lanfranchi PA. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology. 2007 Apr 10;68(15):1213-8.</citation>
    <PMID>17420405</PMID>
  </reference>
  <reference>
    <citation>Khot UN, Binkley PF, Haas GJ, Starling RC. Prospective study of the circadian pattern of blood pressure after heart transplantation. J Heart Lung Transplant. 1996 Apr;15(4):350-9.</citation>
    <PMID>8732593</PMID>
  </reference>
  <reference>
    <citation>Taler SJ, Textor SC, Canzanello VJ, Wilson DJ, Wiesner RH, Krom RA. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. Am J Hypertens. 1995 Jun;8(6):598-605.</citation>
    <PMID>7544983</PMID>
  </reference>
  <reference>
    <citation>Toprak A, Koc M, Tezcan H, Ozener IC, Oktay A, Akoglu E. Night-time blood pressure load is associated with higher left ventricular mass index in renal transplant recipients. J Hum Hypertens. 2003 Apr;17(4):239-44.</citation>
    <PMID>12692568</PMID>
  </reference>
  <reference>
    <citation>Wadei HM, Amer H, Taler SJ, Cosio FG, Griffin MD, Grande JP, Larson TS, Schwab TR, Stegall MD, Textor SC. Diurnal blood pressure changes one year after kidney transplantation: relationship to allograft function, histology, and resistive index. J Am Soc Nephrol. 2007 May;18(5):1607-15. Epub 2007 Apr 4.</citation>
    <PMID>17409307</PMID>
  </reference>
  <reference>
    <citation>Covic A, Gusbeth-Tatomir P, Mardare N, Buhaescu I, Goldsmith DJ. Dynamics of the circadian blood pressure profiles after renal transplantation. Transplantation. 2005 Nov 15;80(9):1168-73.</citation>
    <PMID>16314781</PMID>
  </reference>
  <reference>
    <citation>Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS, Bradley TD. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J. 2003 Feb;21(2):241-7.</citation>
    <PMID>12608436</PMID>
  </reference>
  <reference>
    <citation>Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am J Kidney Dis. 2007 Dec;50(6):908-17.</citation>
    <PMID>18037091</PMID>
  </reference>
  <reference>
    <citation>Hermida RC, Ayala DE, Fernández JR, Calvo C. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension. 2008 Jan;51(1):69-76. Epub 2007 Oct 29.</citation>
    <PMID>17968001</PMID>
  </reference>
  <reference>
    <citation>Hermida RC, Ayala DE, Calvo C, López JE, Mojón A, Fontao MJ, Soler R, Fernández JR. Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension. 2005 Oct;46(4):1053-9. Epub 2005 Aug 8.</citation>
    <PMID>16087787</PMID>
  </reference>
  <reference>
    <citation>Hermida RC, Ayala DE, Calvo C. Administration-time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr Opin Nephrol Hypertens. 2005 Sep;14(5):453-9. Review.</citation>
    <PMID>16046904</PMID>
  </reference>
  <reference>
    <citation>Hermida RC, Calvo C, Ayala DE, López JE. Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension. 2005 Oct;46(4):960-8. Epub 2005 Sep 6.</citation>
    <PMID>16144987</PMID>
  </reference>
  <reference>
    <citation>Gali B, Whalen FX Jr, Gay PC, Olson EJ, Schroeder DR, Plevak DJ, Morgenthaler TI. Management plan to reduce risks in perioperative care of patients with presumed obstructive sleep apnea syndrome. J Clin Sleep Med. 2007 Oct 15;3(6):582-8.</citation>
    <PMID>17993039</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2010</study_first_submitted>
  <study_first_submitted_qc>March 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2010</study_first_posted>
  <last_update_submitted>May 28, 2013</last_update_submitted>
  <last_update_submitted_qc>May 28, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Hani M. Wadei</investigator_full_name>
    <investigator_title>Cons-Nephrology</investigator_title>
  </responsible_party>
  <keyword>kidney transplantation</keyword>
  <keyword>hypertension</keyword>
  <keyword>chronotherapy</keyword>
  <keyword>graft function</keyword>
  <keyword>circadian pattern</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

